Trial Profile
A Multi-center, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of MP4OX Treatment, in Addition to Standard Treatment, in Severely Injured Trauma Patients With Lactic Acidosis Due to Hemorrhagic Shock
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Human haemoglobin (Primary)
- Indications Lactic acidosis
- Focus Therapeutic Use
- Sponsors Sangart
- 10 Oct 2014 New trial record